142 related articles for article (PubMed ID: 11137881)
1. Beta-amyloid (1-42) affects MTT reduction in astrocytes: implications for vesicular trafficking and cell functionality.
Kerokoski P; Soininen H; Pirttilä T
Neurochem Int; 2001 Feb; 38(2):127-34. PubMed ID: 11137881
[TBL] [Abstract][Full Text] [Related]
2. Amyloid beta protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes.
Abe K; Saito H
Neurosci Res; 1998 Aug; 31(4):295-305. PubMed ID: 9809588
[TBL] [Abstract][Full Text] [Related]
3. Amyloid beta-peptide alters the distribution of early endosomes and inhibits phosphorylation of Akt in the presence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT).
Kubo T; Nishimura S; Oda T
Brain Res Mol Brain Res; 2002 Oct; 106(1-2):94-100. PubMed ID: 12393269
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of MTT, a tetrazolium salt, exocytosis by amyloid beta-protein and chloroquine in cultured rat astrocytes.
Isobe I; Michikawa M; Yanagisawa K
Neurosci Lett; 1999 May; 266(2):129-32. PubMed ID: 10353344
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of V-type ATPases, bafilomycin A1 and concanamycin A, protect against beta-amyloid-mediated effects on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction.
Kane MD; Schwarz RD; St Pierre L; Watson MD; Emmerling MR; Boxer PA; Walker GK
J Neurochem; 1999 May; 72(5):1939-47. PubMed ID: 10217271
[TBL] [Abstract][Full Text] [Related]
6. Congo red reverses amyloid beta protein-induced cellular stress in astrocytes.
Abe K; Kato M; Saito H
Neurosci Res; 1997 Oct; 29(2):129-34. PubMed ID: 9359461
[TBL] [Abstract][Full Text] [Related]
7. The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides.
Shearman MS; Hawtin SR; Tailor VJ
J Neurochem; 1995 Jul; 65(1):218-27. PubMed ID: 7790863
[TBL] [Abstract][Full Text] [Related]
8. Amyloid beta-peptide-induced inhibition of MTT reduction in PC12h and C1300 neuroblastoma cells: effect of nitroprusside.
Takenouchi T; Munekata E
Peptides; 1998; 19(2):365-72. PubMed ID: 9493870
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis.
Liu Y; Schubert D
J Neurochem; 1997 Dec; 69(6):2285-93. PubMed ID: 9375659
[TBL] [Abstract][Full Text] [Related]
10. Both oxidative stress-dependent and independent effects of amyloid beta protein are detected by 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction assay.
Abe K; Saito H
Brain Res; 1999 May; 830(1):146-54. PubMed ID: 10350568
[TBL] [Abstract][Full Text] [Related]
11. Cellular MTT reduction distinguishes the mechanism of action of beta-amyloid from that of tachykinin receptor peptides.
Shearman MS
Neuropeptides; 1996 Apr; 30(2):125-32. PubMed ID: 8771554
[TBL] [Abstract][Full Text] [Related]
12. Substrate-dependence of reduction of MTT: a tetrazolium dye differs in cultured astroglia and neurons.
Takahashi S; Abe T; Gotoh J; Fukuuchi Y
Neurochem Int; 2002 Apr; 40(5):441-8. PubMed ID: 11821152
[TBL] [Abstract][Full Text] [Related]
13. Beta-amyloid-induced cell toxicity: enhancement of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide-dependent cell death.
Hertel C; Hauser N; Schubenel R; Seilheimer B; Kemp JA
J Neurochem; 1996 Jul; 67(1):272-6. PubMed ID: 8667002
[TBL] [Abstract][Full Text] [Related]
14. Measurement of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction activity and lactate dehydrogenase release using MTT.
Abe K; Matsuki N
Neurosci Res; 2000 Dec; 38(4):325-9. PubMed ID: 11164558
[TBL] [Abstract][Full Text] [Related]
15. Amyloid beta peptide (25-35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures.
Harris ME; Wang Y; Pedigo NW; Hensley K; Butterfield DA; Carney JM
J Neurochem; 1996 Jul; 67(1):277-86. PubMed ID: 8667003
[TBL] [Abstract][Full Text] [Related]
16. The free radical antioxidant vitamin E protects cortical synaptosomal membranes from amyloid beta-peptide(25-35) toxicity but not from hydroxynonenal toxicity: relevance to the free radical hypothesis of Alzheimer's disease.
Subramaniam R; Koppal T; Green M; Yatin S; Jordan B; Drake J; Butterfield DA
Neurochem Res; 1998 Nov; 23(11):1403-10. PubMed ID: 9814551
[TBL] [Abstract][Full Text] [Related]
17. Endocytosis and Transcytosis of Amyloid-β Peptides by Astrocytes: A Possible Mechanism for Amyloid-β Clearance in Alzheimer's Disease.
Domínguez-Prieto M; Velasco A; Tabernero A; Medina JM
J Alzheimers Dis; 2018; 65(4):1109-1124. PubMed ID: 30103329
[TBL] [Abstract][Full Text] [Related]
18. Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death.
Wogulis M; Wright S; Cunningham D; Chilcote T; Powell K; Rydel RE
J Neurosci; 2005 Feb; 25(5):1071-80. PubMed ID: 15689542
[TBL] [Abstract][Full Text] [Related]
19. Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of beta-amyloid in rat PC12 cells.
Pollack SJ; Sadler II; Hawtin SR; Tailor VJ; Shearman MS
Neurosci Lett; 1995 Jan; 184(2):113-6. PubMed ID: 7724043
[TBL] [Abstract][Full Text] [Related]
20. Abeta mediated diminution of MTT reduction--an artefact of single cell culture?
Rönicke R; Klemm A; Meinhardt J; Schröder UH; Fändrich M; Reymann KG
PLoS One; 2008 Sep; 3(9):e3236. PubMed ID: 18800168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
